Skip to contentHasnain Faheem — BIOGEN IDEC INC insider: 203 transactions · InsiderLensHasnain Faheem
- Director at IMMUNIC, INC. · on record since Aug 15, 2016
- Director at TERCICA INC · on record since Feb 28, 2008
- EVP, Oncology/Rheumatology SBU at BIOGEN IDEC INC · on record since Feb 14, 2008
- Director at FIRST ALBANY COMPANIES INC · on record since Dec 19, 2008
- President & CEO at FIRST ALBANY COMPANIES INC · on record since Dec 19, 2008
- Director at PDL BIOPHARMA, INC. · on record since Oct 3, 2008
- President & CEO at PDL BIOPHARMA, INC. · on record since Oct 3, 2008
- Director at Somaxon Pharmaceuticals, Inc. · on record since Sep 21, 2010
- Director at AMBIT BIOSCIENCES CORP · on record since May 21, 2013
- Director at Receptos, Inc. · on record since May 14, 2013
- Director at ZETA ACQUISITION CORP III · on record since Jun 4, 2026
- President & CEO at Receptos, Inc. · on record since Nov 12, 2014
- Director at Forte Biosciences, Inc. · on record since Apr 21, 2017
- Director at Gossamer Bio, Inc. · on record since Mar 26, 2019
- Director at Mirati Therapeutics, Inc. · on record since Feb 20, 2019
- Director at Nuvation Bio Inc. · on record since Jun 30, 2020
- President & CEO at Gossamer Bio, Inc. · on record since Mar 26, 2019
Insider trading activity of Hasnain Faheem
- Transactions on record
- 203
- since Feb 8, 2006
- Open-market buys
- 14
- $5.9M
- Open-market sells
- 42
- $26.4M
- Companies traded
- 13
- last filing Jun 4, 2026
Figures computed from official regulatory filings — methodology.
Companies where Hasnain Faheem has traded
- ZETA ACQUISITION CORP III16 tx · $465.8K · Jun 4, 2026
- Gossamer Bio, Inc.48 tx · $4.6M · Mar 20, 2026
- Mirati Therapeutics, Inc.17 tx · $870K · Jan 23, 2024
- Nuvation Bio Inc.3 tx · $300K · Feb 26, 2021
- Forte Biosciences, Inc.9 tx · $2.2M · Oct 4, 2019
- IMMUNIC, INC.8 tx · $1M · Sep 17, 2018
- Receptos, Inc.12 tx · $102.8M · Aug 27, 2015
- AMBIT BIOSCIENCES CORP9 tx · $1.7M · Nov 12, 2014
- Somaxon Pharmaceuticals, Inc.8 tx · Mar 8, 2013
Track record of Hasnain Faheem
Statistical track record
Free- Open-market buys
- 14
- Last buy
- Jun 21, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Hasnain Faheem
Co-insiders of Hasnain Faheem
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
9 tx · $13.8M · Apr 23, 2010
Boxer Asset Management Inc.Mirati Therapeutics, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 4, 2026 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Mar 20, 2026 | AwardD | 1,540,000 | — | — | SEC |
| Mar 20, 2026 | AwardD | 650,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -43,500 | — | — | SEC |
| Mar 20, 2026 | AwardD | 1,680,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -1,680,000 | — | — | SEC |
| Mar 20, 2026 | AwardD | 325,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -650,000 | — | — | SEC |
| Mar 20, 2026 | AwardD | 544,500 | — | — | SEC |
| Mar 20, 2026 | AwardD | 1,312,500 | — | — | SEC |
| Mar 20, 2026 | OtherD | -47,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -544,500 | — | — | SEC |
| Mar 20, 2026 | AwardD | 47,000 | — | — | SEC |
| Mar 20, 2026 | AwardD | 544,500 | — | — | SEC |
| Mar 20, 2026 | OtherD | -544,500 | — | — | SEC |
| Mar 20, 2026 | OtherD | -1,540,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -437,500 | — | — | SEC |
| Mar 20, 2026 | AwardD | 43,500 | — | — | SEC |
| Mar 20, 2026 | AwardD | 437,500 | — | — | SEC |
| Mar 20, 2026 | OtherD | -325,000 | — | — | SEC |
| Mar 20, 2026 | OtherD | -1,312,500 | — | — | SEC |
| Jan 5, 2026 | Award | 280,000 | 0.00 USD | $0 | SEC |
| Jan 5, 2026 | AwardD | 1,680,000 | 0.00 USD | $0 | SEC |
| Dec 10, 2025 | Exercise | 10,000 | 3.12 USD | $31.2K | SEC |
| Dec 10, 2025 | Sell | -10,000 | 10.98 USD | $109.8K | SEC |